List of serched triples

A total of 22252 records found

#15352 middle Confidence
Subject: patient_age (Patient characteristics)
is_not_predictive_of
Object: cancer_on_follow_up_biopsy (Disease phenotype)
Original: Serum prostate-specific antigen/ digital rectal examination result/ and patient age#were not predictive of#cancer on follow-up biopsy
🏥 Diagnostic significance 📄 PMID: 9610588
#15351 middle Confidence
Subject: digital_rectal_examination_result (Clinical examination)
is_not_predictive_of
Object: cancer_on_follow_up_biopsy (Disease phenotype)
Original: Serum prostate-specific antigen/ digital rectal examination result/ and patient age#were not predictive of#cancer on follow-up biopsy
🏥 Diagnostic significance 📄 PMID: 9610588
#15350 middle Confidence
Subject: serum_prostate_specific_antigen (Tumor markers)
is_not_predictive_of
Object: cancer_on_follow_up_biopsy (Disease phenotype)
Original: Serum prostate-specific antigen/ digital rectal examination result/ and patient age#were not predictive of#cancer on follow-up biopsy
🏥 Diagnostic significance 📄 PMID: 9610588
#15349 middle Confidence
Subject: cells (cell)
have
Object: prominent_nucleoli (Morphological characteristics)
Original: Cells#had#high nuclear to cytoplasmic ratios and prominent nucleoli
🏥 not_specified 📄 PMID: 8989933
#15348 middle Confidence
Subject: cells (cell)
have
Object: high_nuclear_to_cytoplasmic_ratio (Morphological characteristics)
Original: Cells#had#high nuclear to cytoplasmic ratios and prominent nucleoli
🏥 not_specified 📄 PMID: 8989933
#15347 middle Confidence
Subject: lesions (Lesions)
consist_of
Object: nodular_proliferation_of_small_round_cells (Morphological characteristics)
Original: Lesions#consisted of#nodular proliferation of small round cells
🏥 not_specified 📄 PMID: 8989933
#15346 middle Confidence
Subject: cytologic_criteria (Cytological criteria)
includes
Object: irregular_nuclear_borders (Morphological characteristics)
Original: Cytologic criteria#include#increased nuclear/cytoplasmic ratios and irregular nuclear borders
🏥 Diagnostic significance 📄 PMID: 8062194
#15345 middle Confidence
Subject: cytologic_criteria (Cytological criteria)
includes
Object: increased_nuclear_to_cytoplasmic_ratio (Morphological characteristics)
Original: Cytologic criteria#include#increased nuclear/cytoplasmic ratios and irregular nuclear borders
🏥 Diagnostic significance 📄 PMID: 8062194
#15344 middle Confidence
Subject: Cytologic_features (Cytological characteristics)
predict
Object: mucoepidermoid_carcinoma (Mucoepidermoid carcinoma)
Original: Cytologic features#predict#mucoepidermoid carcinoma
🏥 Diagnostic significance 📄 PMID: 2296840
#15343 middle Confidence
Subject: transurethral_resection_specimens (Surgical specimens)
are_evaluated_for
Object: stage_A_low-grade_adenocarcinoma (Cancer grade)
Original: transurethral resection specimens#are evaluated for#stage A low-grade adenocarcinoma
🏥 Grading 📄 PMID: 7684998
#15342 middle Confidence
Subject: malignant_glands (Malignant glands)
are_recognized_by
Object: abnormal_location (Pathological characteristics)
Original: malignant glands#are recognized by#abnormal size/ shape/ and location
🏥 diagnosis 📄 PMID: 9541939
#15341 middle Confidence
Subject: malignant_glands (Malignant glands)
are_recognized_by
Object: abnormal_shape (Pathological characteristics)
Original: malignant glands#are recognized by#abnormal size/ shape/ and location
🏥 diagnosis 📄 PMID: 9541939
#15340 middle Confidence
Subject: malignant_glands (Malignant glands)
are_recognized_by
Object: abnormal_size (Pathological characteristics)
Original: malignant glands#are recognized by#abnormal size/ shape/ and location
🏥 diagnosis 📄 PMID: 9541939
#15339 middle Confidence
Subject: apoptotic_bodies (apoptotic body)
were_seen_in
Object: prostatic_adenocarcinoma (cancer)
Original: apoptotic bodies#were seen fairly frequently in#prostatic adenocarcinoma
🏥 diagnosis 📄 PMID: 16260270
#15338 middle Confidence
Subject: nuclear_features (Nuclear characteristics)
correlate_with
Object: PD-L1_expression (Protein expression)
Original: nuclear features#might be correlated with#PD-L1 expression in lung adenocarcinoma
🏥 Diagnosis/Prognosis 🧬 CD274 📄 PMID: 30275232
#15337 middle Confidence
Subject: patient (patient)
was_treated_with
Object: prednisone (Glucocorticoids)
Original: patient#was treated with#six cycles of cyclophosphamide/ doxorubicin/ vincristine and prednisone (CHOP)
🏥 treat 📄 PMID: 16997373
#15336 middle Confidence
Subject: patient (patient)
was_treated_with
Object: vincristine (Chemotherapy drugs)
Original: patient#was treated with#six cycles of cyclophosphamide/ doxorubicin/ vincristine and prednisone (CHOP)
🏥 treat 📄 PMID: 16997373
#15335 middle Confidence
Subject: patient (patient)
was_treated_with
Object: doxorubicin (Chemotherapy drugs)
Original: patient#was treated with#six cycles of cyclophosphamide/ doxorubicin/ vincristine and prednisone (CHOP)
🏥 treat 📄 PMID: 16997373
#15334 middle Confidence
Subject: patient (patient)
was_treated_with
Object: cyclophosphamide (Chemotherapy drugs)
Original: patient#was treated with#six cycles of cyclophosphamide/ doxorubicin/ vincristine and prednisone (CHOP)
🏥 treat 📄 PMID: 16997373
#15333 middle Confidence
Subject: monoclonal_cells (Cell population)
expresses
Object: FMC7 (Membrane Protein)
Original: monoclonal cells#were characterized by#CD45+/ CD19+/ CD20+/ CD5+/ HLA-DR+/ CD10-/ CD23+/-/ CD38+/ FMC7-
🏥 not_specified 📄 PMID: 16997373